The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells
Christopher Noyes(Brown University), Mamiko Yajima(Brown University), Erik H. Knelson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Saradha Miriyala(Brown University), Yusuke Suita(Rhode Island Hospital), Nikos Tapinos(Brown University), Tetsuo Tani(Keio University), Derek Xu(Brown University), Chiaki Takahashi(Kanazawa University), Nagib Ahsan(University of Oklahoma), Shunsuke Kitajima(Japanese Foundation For Cancer Research), Tran C. Thai(Dana-Farber Cancer Institute), David A. Barbie(Dana-Farber Cancer Institute), Junko Murai(Ehime University), Amir Vajdi(Dana-Farber Cancer Institute), Shakson Isaac(Harvard University), Fengkai Li(Shanghai Medical College of Fudan University)
Cited by 2
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701